Aytu BioPharma Inc (AYTU): Rasio rega marang dodolan

Aytu BioPharma, Inc. (AYTU) is expanding sales of pediatric ADHD medications and reducing logistics costs. P/S fluctuations confirm the business valuation trend, where the value 0.30 represents the current metric. Resilience is driven by the diversification of drug distribution rights. Personnel stability is maintained through the targeted hiring of specialized managers and compliance experts.

AYTU: Multiplikator P/S aytubio.com 04.07.2022 - 14.11.2026

Rincian metrik lan analitis perusahaan Aytu BioPharma, Inc. (AYTU)

- rega saham lan konsensus proyeksi valuasi:

Bagan owah-owahan rega aytubio.com|AYTU - Bagan rega target

- data kapitalisasi bursa:

Biji pasar Aytu Therapeutics|AYTU - Nilai Perusahaan

- indikator nilai aset resik miturut neraca:

Nilai Akuntansi Saham Aytu BioPharma|AYTU - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku aytubio.com|AYTU - Aset Agregat Perusahaan

- statistik kawajiban utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi Aytu BioPharma, Inc.|AYTU - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas aytubio.com|AYTU - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Aytu Therapeutics|AYTU - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Aytu BioPharma|Likuiditas darurat aytubio.com

- informasi bathi lan kelipatan valuasi:

AYTU - Penghasilan resik|Bathi resik mangsa ngarep Aytu BioPharma, Inc.|AYTU - Koefisien rega marang bathi|Pangali Forward P/E aytubio.com|AYTU - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Aytu Therapeutics|AYTU - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Aytu BioPharma|AYTU - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan aytubio.com|AYTU - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Aytu BioPharma, Inc.

- rincian pendapatan lan dodolan emiten:

AYTU - Pendapatan perusahaan|Pendapatan sing dikarepake perusahaan aytubio.com|AYTU - Multiplikator P/S|Rega forward marang dodolan Aytu Therapeutics

Analisis umum perusahaan:AYTU Aytu BioPharma Inc

Aytu BioPharma's specialization in pediatric ADHD medications generates a steady revenue stream. This cash flow serves as the basis for calculating the P/S ratio, which compares the business's market value to its annual turnover. This metric determines how much an investor pays per unit of sales, revealing whether the asset is overvalued or undervalued. Analyzing the current P/S level allows for an assessment of the capitalization's resilience to market volatility.

Perusahaan pesaing

VRTX (vrtx.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Alnylam ALNY|INSM (Insmed Inc.) - Rasio rega marang dodolan|United Therapeutics Corp. - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan BMRN (BioMarin Corp)|BBIO: Multiplikator P/S|BGM Group (BGM) - Multiplikator P/S|Rasio rega marang pendapatan Cogent Biosciences, Inc.|XERS: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Keros Pharma (KROS)|Kapitalisasi marang pendapatan Arcturus Corp ARCT|Multiplikator P/S ETON (Eton Pharmaceuticals)|Multiplikator P/S kamada.com KMDA|Fulcrum Therapeutics, Inc. - Multiplikator P/S|ABEO - Multiplikator P/S|MREO (mereobiopharma.com) - Kapitalisasi marang pendapatan|Rega marang dodolan Protalix BioTherapeutics, Inc (PLX)|Kapitalisasi marang pendapatan PLRX|APLT (appliedtherapeutics.com) - Kapitalisasi marang volume dodolan|Kapitalisasi marang pendapatan RNTX (Rein Therapeutics)|Multiplikator P/S gelteq.com (GELS)|Chemomab Therapeutics Ltd. - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan SRXH|Polyrizon Ltd. - Multiplikator P/S|AEZS: Rasio rega marang pendapatan|CYTH: Multiplikator P/S|INZY - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Reneo Pharma|Rega marang dodolan COSCIENS Bio CSCI